找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hepatitis C: Epidemiology, Prevention and Elimination; Volume 1 Angelos Hatzakis Book 2021 Springer Nature Switzerland AG 2021 pathogenesis

[復(fù)制鏈接]
樓主: Embolism
41#
發(fā)表于 2025-3-28 14:48:26 | 只看該作者
42#
發(fā)表于 2025-3-28 21:50:53 | 只看該作者
Laboratory Diagnosis,ection of HCV RNA to confirm an active infection. Assays that detect and quantify HCV core antigen provide an alternative to testing for HCV RNA. Molecular assays to quantify the HCV RNA load, determine the HCV genotype, and detect drug resistance-associated mutations are established in well-resourc
43#
發(fā)表于 2025-3-29 02:40:30 | 只看該作者
44#
發(fā)表于 2025-3-29 03:59:38 | 只看該作者
45#
發(fā)表于 2025-3-29 10:34:58 | 只看該作者
Natural History of Hepatitis C Infection,tive antiviral treatments allowed observational studies of large untreated cohorts. However, deep understanding of HCV natural history has been always hampered by the asymptomatic course of the disease, both in the acute and in the chronic infection phase. As a consequence, many studies conducted in
46#
發(fā)表于 2025-3-29 12:35:51 | 只看該作者
Epidemiology: Modeling of Natural History,hree important ingredients: disease stages, allowed transitions between stages, and corresponding stage-specific transition probabilities. This chapter reviews the approaches that have been used to model the natural history of chronic hepatitis C (CHC). A commonly used approach is to consider diseas
47#
發(fā)表于 2025-3-29 17:22:52 | 只看該作者
48#
發(fā)表于 2025-3-29 21:46:44 | 只看該作者
Hepatitis C Elimination and Advocacy Groups, of hepatitis C on the global public health agenda and resulted in the commitment by 193 countries to eliminate hepatitis C by 2030; and advocacy for viral hepatitis at a global level really began at a meeting of patient representatives from around the world in Barcelona in 2007.
49#
發(fā)表于 2025-3-30 03:01:03 | 只看該作者
HCV Elimination in Australia,d 1990s, followed by a decline in early- to mid-2000s, initially related to reduced heroin supply [1]. Ongoing HCV incidence of several 1000 infections/year over the last decade has been despite high-coverage harm-reduction services for people who inject drugs (PWID) [2].
50#
發(fā)表于 2025-3-30 04:28:33 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 13:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
吉林省| 陇南市| 吴堡县| 玉龙| 沅陵县| 台东市| 澄城县| 昭苏县| 喀喇沁旗| 万州区| 屯昌县| 辰溪县| 潜山县| 桂阳县| 永新县| 海宁市| 乌鲁木齐县| 临清市| 竹山县| 寿阳县| 武鸣县| 呼和浩特市| 且末县| 清新县| 元江| 宁津县| 科技| 信宜市| 峨山| 尚义县| 来宾市| 延庆县| 金山区| 高台县| 兴隆县| 庆城县| 辰溪县| 阜南县| 富裕县| 房山区| 康马县|